ID   UCK1_HUMAN              Reviewed;         277 AA.
AC   Q9HA47; Q5JT09; Q5JT10; Q5JT12; Q5JT13; Q6IA74; Q96BJ0;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   18-JUN-2025, entry version 185.
DE   RecName: Full=Uridine-cytidine kinase 1;
DE            Short=UCK 1;
DE            EC=2.7.1.48 {ECO:0000269|PubMed:11306702};
DE   AltName: Full=Cytidine monophosphokinase 1;
DE   AltName: Full=Uridine monophosphokinase 1;
GN   Name=UCK1; Synonyms=URK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RX   PubMed=11306702; DOI=10.1124/mol.59.5.1181;
RA   Van Rompay A.R., Norda A., Linden K., Johansson M., Karlsson A.;
RT   "Phosphorylation of uridine and cytidine nucleoside analogs by two human
RT   uridine-cytidine kinases.";
RL   Mol. Pharmacol. 59:1181-1186(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ho Y.S., Johnson R.K.;
RT   "Human uridine kinase from prostate cancer cell line (LNCaP).";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Xin Y.R., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA similar to Mus musculus uridine kinase mRNA.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Hippocampus, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-251 AND SER-253, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 22-243 IN COMPLEX WITH ADP.
RG   Northeast structural genomics consortium (NESG);
RT   "Structure of human uridine-cytidine kinase 1.";
RL   Submitted (JAN-2007) to the PDB data bank.
CC   -!- FUNCTION: Phosphorylates uridine and cytidine to uridine monophosphate
CC       and cytidine monophosphate (PubMed:11306702). Does not phosphorylate
CC       deoxyribonucleosides or purine ribonucleosides (PubMed:11306702). Can
CC       use ATP or GTP as a phosphate donor (PubMed:11306702). Can also
CC       phosphorylate cytidine and uridine nucleoside analogs such as 6-
CC       azauridine, 5-fluorouridine, 4-thiouridine, 5-bromouridine, N(4)-
CC       acetylcytidine, N(4)-benzoylcytidine, 5-fluorocytidine, 2-thiocytidine,
CC       5-methylcytidine, and N(4)-anisoylcytidine (PubMed:11306702).
CC       {ECO:0000269|PubMed:11306702}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uridine + ATP = UMP + ADP + H(+); Xref=Rhea:RHEA:16825,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16704, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57865, ChEBI:CHEBI:456216; EC=2.7.1.48;
CC         Evidence={ECO:0000269|PubMed:11306702};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cytidine + ATP = CMP + ADP + H(+); Xref=Rhea:RHEA:24674,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17562, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:456216; EC=2.7.1.48;
CC         Evidence={ECO:0000269|PubMed:11306702};
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via salvage pathway;
CC       CTP from cytidine: step 1/3. {ECO:0000269|PubMed:11306702}.
CC   -!- PATHWAY: Pyrimidine metabolism; UMP biosynthesis via salvage pathway;
CC       UMP from uridine: step 1/1. {ECO:0000269|PubMed:11306702}.
CC   -!- INTERACTION:
CC       Q9HA47-2; P22607: FGFR3; NbExp=3; IntAct=EBI-16434682, EBI-348399;
CC       Q9HA47-2; P06396: GSN; NbExp=3; IntAct=EBI-16434682, EBI-351506;
CC       Q9HA47-2; A0A0S2Z5Y6: UCK1; NbExp=3; IntAct=EBI-16434682, EBI-16434671;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9HA47-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HA47-2; Sequence=VSP_041269;
CC       Name=3;
CC         IsoId=Q9HA47-3; Sequence=VSP_045174;
CC       Name=4;
CC         IsoId=Q9HA47-4; Sequence=VSP_056748;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11306702}.
CC   -!- SIMILARITY: Belongs to the uridine kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF237290; AAK28324.1; -; mRNA.
DR   EMBL; AF254133; AAK49122.1; -; mRNA.
DR   EMBL; AF125106; AAL75943.1; -; mRNA.
DR   EMBL; AK022317; BAB14010.1; -; mRNA.
DR   EMBL; AK295471; BAG58400.1; -; mRNA.
DR   EMBL; CR457281; CAG33562.1; -; mRNA.
DR   EMBL; AL358781; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW87983.1; -; Genomic_DNA.
DR   EMBL; BC015547; AAH15547.1; -; mRNA.
DR   EMBL; BC091495; AAH91495.1; -; mRNA.
DR   CCDS; CCDS48046.1; -. [Q9HA47-2]
DR   CCDS; CCDS59151.1; -. [Q9HA47-3]
DR   CCDS; CCDS59152.1; -. [Q9HA47-4]
DR   CCDS; CCDS6944.1; -. [Q9HA47-1]
DR   RefSeq; NP_001129426.1; NM_001135954.3. [Q9HA47-2]
DR   RefSeq; NP_001248379.1; NM_001261450.3. [Q9HA47-3]
DR   RefSeq; NP_001248380.1; NM_001261451.3. [Q9HA47-4]
DR   RefSeq; NP_001305448.1; NM_001318519.1.
DR   RefSeq; NP_113620.1; NM_031432.5. [Q9HA47-1]
DR   PDB; 2JEO; X-ray; 2.50 A; A=22-243.
DR   PDB; 2UVQ; X-ray; 3.00 A; A=22-243.
DR   PDBsum; 2JEO; -.
DR   PDBsum; 2UVQ; -.
DR   AlphaFoldDB; Q9HA47; -.
DR   SMR; Q9HA47; -.
DR   BioGRID; 123681; 20.
DR   FunCoup; Q9HA47; 960.
DR   IntAct; Q9HA47; 11.
DR   STRING; 9606.ENSP00000361285; -.
DR   ChEMBL; CHEMBL5682; -.
DR   DrugCentral; Q9HA47; -.
DR   GlyGen; Q9HA47; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9HA47; -.
DR   MetOSite; Q9HA47; -.
DR   PhosphoSitePlus; Q9HA47; -.
DR   BioMuta; UCK1; -.
DR   DMDM; 20455360; -.
DR   jPOST; Q9HA47; -.
DR   MassIVE; Q9HA47; -.
DR   PaxDb; 9606-ENSP00000361285; -.
DR   PeptideAtlas; Q9HA47; -.
DR   ProteomicsDB; 63191; -.
DR   ProteomicsDB; 63192; -.
DR   ProteomicsDB; 81375; -. [Q9HA47-1]
DR   ProteomicsDB; 81376; -. [Q9HA47-2]
DR   Pumba; Q9HA47; -.
DR   Antibodypedia; 31627; 339 antibodies from 22 providers.
DR   DNASU; 83549; -.
DR   Ensembl; ENST00000372208.7; ENSP00000361282.3; ENSG00000130717.13. [Q9HA47-2]
DR   Ensembl; ENST00000372210.7; ENSP00000361284.3; ENSG00000130717.13. [Q9HA47-3]
DR   Ensembl; ENST00000372211.7; ENSP00000361285.3; ENSG00000130717.13. [Q9HA47-4]
DR   Ensembl; ENST00000372215.5; ENSP00000361289.4; ENSG00000130717.13. [Q9HA47-1]
DR   GeneID; 83549; -.
DR   KEGG; hsa:83549; -.
DR   MANE-Select; ENST00000372215.5; ENSP00000361289.4; NM_031432.5; NP_113620.1.
DR   UCSC; uc004cay.4; human. [Q9HA47-1]
DR   AGR; HGNC:14859; -.
DR   CTD; 83549; -.
DR   DisGeNET; 83549; -.
DR   GeneCards; UCK1; -.
DR   HGNC; HGNC:14859; UCK1.
DR   HPA; ENSG00000130717; Low tissue specificity.
DR   MIM; 609328; gene.
DR   OpenTargets; ENSG00000130717; -.
DR   VEuPathDB; HostDB:ENSG00000130717; -.
DR   eggNOG; KOG4203; Eukaryota.
DR   GeneTree; ENSGT01020000230412; -.
DR   HOGENOM; CLU_021278_1_4_1; -.
DR   InParanoid; Q9HA47; -.
DR   OMA; PQSTVCE; -.
DR   OrthoDB; 10257085at2759; -.
DR   PAN-GO; Q9HA47; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9HA47; -.
DR   BioCyc; MetaCyc:HS05429-MONOMER; -.
DR   BRENDA; 2.7.1.48; 2681.
DR   PathwayCommons; Q9HA47; -.
DR   Reactome; R-HSA-73614; Pyrimidine salvage.
DR   SABIO-RK; Q9HA47; -.
DR   SignaLink; Q9HA47; -.
DR   SIGNOR; Q9HA47; -.
DR   UniPathway; UPA00574; UER00637.
DR   UniPathway; UPA00579; UER00640.
DR   BioGRID-ORCS; 83549; 16 hits in 1158 CRISPR screens.
DR   ChiTaRS; UCK1; human.
DR   EvolutionaryTrace; Q9HA47; -.
DR   GenomeRNAi; 83549; -.
DR   Pharos; Q9HA47; Tbio.
DR   PRO; PR:Q9HA47; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9HA47; protein.
DR   Bgee; ENSG00000130717; Expressed in pancreatic ductal cell and 170 other cell types or tissues.
DR   ExpressionAtlas; Q9HA47; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043771; F:cytidine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004849; F:uridine kinase activity; IDA:UniProtKB.
DR   GO; GO:0044211; P:CTP salvage; IDA:UniProtKB.
DR   GO; GO:0044206; P:UMP salvage; IDA:UniProtKB.
DR   CDD; cd02023; UMPK; 1.
DR   FunFam; 3.40.50.300:FF:000297; Uridine-cytidine kinase 2; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR006083; PRK/URK.
DR   InterPro; IPR000764; Uridine_kinase-like.
DR   NCBIfam; NF004018; PRK05480.1; 1.
DR   NCBIfam; TIGR00235; udk; 1.
DR   PANTHER; PTHR10285; URIDINE KINASE; 1.
DR   Pfam; PF00485; PRK; 1.
DR   PRINTS; PR00988; URIDINKINASE.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   neXtProt; NX_Q9HA47; -.
DR   PharmGKB; PA134861770; -.
DR   TreeFam; TF316686; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Transferase.
FT   CHAIN           1..277
FT                   /note="Uridine-cytidine kinase 1"
FT                   /id="PRO_0000164453"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          247..277
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        268..277
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        65
FT                   /evidence="ECO:0000250|UniProtKB:B2BW43"
FT   BINDING         30..38
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|Ref.12"
FT   BINDING         87
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZX2"
FT   BINDING         115
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZX2"
FT   BINDING         120
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZX2"
FT   BINDING         169
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZX2"
FT   BINDING         178
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZX2"
FT   BINDING         186
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BZX2"
FT   BINDING         215
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|Ref.12"
FT   MOD_RES         251
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         253
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         28..36
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045174"
FT   VAR_SEQ         28..36
FT                   /note="VSGGTASGK -> DERFQAGIPLLCLQ (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_056748"
FT   VAR_SEQ         170..277
FT                   /note="VLRDVRRGRDLEQILTQYTTFVKPAFEEFCLPTKKYADVIIPRGVDNMVAIN
FT                   LIVQHIQDILNGDICKWHRGGSNGRSYKRTFSEPGDHPGMLTSGKRSHLESSSRPH ->
FT                   DKEVCRCDHPARSGQYGCHQPDRAAHPGHSEW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041269"
FT   CONFLICT        8..17
FT                   /note="DCESPAPEAD -> GARARAGAN (in Ref. 3; AAL75943)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        56..57
FT                   /note="QR -> HG (in Ref. 3; AAL75943)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        175
FT                   /note="R -> H (in Ref. 5; CAG33562)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="S -> T (in Ref. 3; AAL75943)"
FT                   /evidence="ECO:0000305"
FT   STRAND          23..29
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           36..46
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           49..51
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           54..56
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   STRAND          58..63
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           64..67
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           73..80
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           89..91
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           94..105
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   STRAND          110..112
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   TURN            117..120
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   STRAND          133..138
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   TURN            140..143
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           146..149
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   STRAND          153..159
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           162..173
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           180..189
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           191..198
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           200..205
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   STRAND          207..213
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   HELIX           217..232
FT                   /evidence="ECO:0007829|PDB:2JEO"
FT   CONFLICT        Q9HA47-2:180
FT                   /note="A -> T (in Ref. 8; AAH15547)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   277 AA;  31435 MW;  AFD9ED92780CD502 CRC64;
     MASAGGEDCE SPAPEADRPH QRPFLIGVSG GTASGKSTVC EKIMELLGQN EVEQRQRKVV
     ILSQDRFYKV LTAEQKAKAL KGQYNFDHPD AFDNDLMHRT LKNIVEGKTV EVPTYDFVTH
     SRLPETTVVY PADVVLFEGI LVFYSQEIRD MFHLRLFVDT DSDVRLSRRV LRDVRRGRDL
     EQILTQYTTF VKPAFEEFCL PTKKYADVII PRGVDNMVAI NLIVQHIQDI LNGDICKWHR
     GGSNGRSYKR TFSEPGDHPG MLTSGKRSHL ESSSRPH
//
